WALD
Waldencast plc
NASDAQ · Technology · Software - Application · US
$1.37
+0.00%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
96.7x
EV/EBITDA
−2.2x
Market Cap
$175.72M
MomentumView details →
1D Return
+0.00%
YTD Return
−26.86%
RSI (14)
45.0
ValuationView details →
P/E (Fwd)
96.7x
EV/EBITDA
−2.2x
Market Cap
$175.72M
RSI (14)
45.0
MomentumView details →
1D Return
+0.00%
YTD Return
−26.86%
SummaryUpdated Dec 1, 2025
Waldencast plc (NASDAQ:WALD) is a beauty and wellness company that operates as a platform for acquiring and scaling high-growth beauty brands. Founded through a special purpose acquisition company (SPAC) merger in 2021, the company has positioned itself as a consolidator in the prestige beauty market. Waldencast currently operates two primary brands: Milk Makeup, a Gen Z-focused cosmetics brand, and Obagi Medical, a physician-dispensed skincare line. The company went public in May 2021 and is headquartered in White Plains, New York, with operations spanning multiple international markets including the United States, United Kingdom, and various emerging markets.
Similar companies
Latest newsMore news →
Waldencast completed the sale of its Obagi Medical business to Bridgepoint for up to $460 million.36d agoWaldencast Plc filed a lawsuit in Delaware's Chancery Court against former Obagi CEO Jaime Castle and former parent Cedarwalk Skincare Ltd., alleging a channel-stuffing scheme that inflated Obagi's earnings by $50 million and caused Waldencast to overpay by hundreds of millions of dollars.39d agoThe FDA approved Obagi saypha ChIQ injectable hyaluronic acid gel for Obagi Medical, a brand of Waldencast plc.81d ago